Zepp Health Corporation (ZEPP)

Arcadium Lithium Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	199.95	182.6	352.86	613.64	983.87	985.41
Revenue Growth (YoY)	-15.72%	-48.25%	-42.50%	-37.63%	-0.16%	18.05%
Cost of Revenue	124.92	112.37	260.5	494.78	778.34	781.29
Gross Profit	75.03	70.23	92.36	118.86	205.53	204.13
Selling, General & Admin	75.52	71.33	71.31	103.42	109.66	95.04
Research & Development	45.45	46.16	51.5	77.3	81.08	82.41
Operating Expenses	120.98	117.48	122.81	180.71	190.74	177.45
Operating Income	-45.95	-47.25	-30.45	-61.86	14.79	26.68
Interest Expense	-5.34	-5.55	-6.75	-8.44	-7.07	-3.47
Interest & Investment Income	2.59	3.67	3.09	1.82	2.63	7.06
Earnings From Equity Investments	-4.18	-4.21	1.11	2.68	6.46	-0.73
Other Non Operating Income (Expenses)	-0.79	-0.66	-0.53	6.45	4.32	-0.14
EBT Excluding Unusual Items	-53.67	-54	-33.53	-59.35	21.12	29.41
Gain (Loss) on Sale of Investments	-10.04	-8.12	0.01	6.14	2.13	1.89
Gain (Loss) on Sale of Assets	-	-	-	-	-	8.66
Pretax Income	-63.72	-62.12	-33.52	-53.21	23.25	39.96
Income Tax Expense	13.93	13.69	-2.43	-9.87	1.69	4.77
Earnings From Continuing Operations	-77.64	-75.81	-31.09	-43.35	21.56	35.18
Minority Interest in Earnings	0.03	0.08	0.07	0.1	0.13	-0.15
Net Income	-77.61	-75.73	-31.02	-43.24	21.69	35.04
Net Income to Common	-77.61	-75.73	-31.02	-43.24	21.69	35.04
Net Income Growth	-	-	-	-	-38.09%	-57.58%
Shares Outstanding (Basic)	16	16	15	15	16	16
Shares Outstanding (Diluted)	16	16	15	15	17	16
Shares Change (YoY)	2.08%	6.47%	-1.28%	-6.84%	1.54%	1.72%
EPS (Basic)	-4.84	-4.68	-2.04	-2.81	1.38	2.26
EPS (Diluted)	-4.84	-4.68	-2.08	-2.88	1.31	2.16
EPS Growth	-	-	-	-	-39.27%	-58.10%
Free Cash Flow	-	-25.8	41.01	-118.32	-43.84	11.3
Free Cash Flow Per Share	-	-1.59	2.70	-7.69	-2.65	0.69
Gross Margin	37.52%	38.46%	26.17%	19.37%	20.89%	20.71%
Operating Margin	-22.98%	-25.88%	-8.63%	-10.08%	1.50%	2.71%
Profit Margin	-38.81%	-41.47%	-8.79%	-7.05%	2.21%	3.56%
Free Cash Flow Margin	-	-14.13%	11.62%	-19.28%	-4.46%	1.15%
EBITDA	-42.27	-42.23	-22.76	-53.15	22.96	30.84
EBITDA Margin	-21.14%	-23.13%	-6.45%	-8.66%	2.33%	3.13%
D&A For EBITDA	3.68	5.02	7.69	8.71	8.17	4.16
EBIT	-45.95	-47.25	-30.45	-61.86	14.79	26.68
EBIT Margin	-22.98%	-25.88%	-8.63%	-10.08%	1.50%	2.71%
Effective Tax Rate	-	-	-	-	7.27%	11.94%

Updated May 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q